Brian Edwards

Managing Director at Husoteria Ltd

Ashtead, England, United Kingdom

About me

Dr Edwards trained as a medical doctor at Guy’s Hospital, London and spent 14 years in hospital medicine and clinical research before joining the UK regulatory agency which used to be called the Medicines Control Agency. After 5 years there, he joined a global CRO, Parexel, for six years followed by 18 months at Johnson & Johnson as a deputy qualified person for pharmacovigilance. For 13 years up until 2021, he was Principal Consultant in Pharmacovigilance at NDA Regulatory Science based in the UK. In addition, he co-chairs the ISOP Medication Error Special Interest Group) and Chair of the UK Pharmaceutical Human Factors group. Previously, he chaired the panel overseeing the ‘Drug Safety Surveillance’ module as part of Higher Medical Training for pharmaceutical medicine in the UK between January 2006 and 2012. He was awarded a Fellowship with the International Society of Pharmacovigilance. Currently he is Managing Director of his own consultancy Husoteria Ltd and has been co-leader of the DIA/ASA Benefit Risk Assessment Planning working group since 2020. He was elected back to the Advisory Board of ISOP in 2025 and is Community Coordinator and Director of ISOP Secretariat Ltd. In May 2023 he was awarded a Global Fellowship in Medicines Development. He is the Co-Chair of the Scientific Committee for ISOP 2025.

Schedule

Panel Discussion: Beyond Compliance: Building a Proactive Drug Safety Culture

How leading organisations are embedding pharmacovigilance into decision-making, culture, and strategy - moving from reactive compliance to proactive patient safety.

How can pharmacovigilance move from a compliance function to a strategic driver of patient safety?
What does true cross-functional ownership of drug safety look like in practice?
Are current KPIs driving the right behaviours or just ticking boxes?
How can leadership create accountability for proactive safety decisions?